A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).

Takao NamikiShin TakayamaRyutaro AritaTadashi IshiiMosaburo KainumaToshiaki MakinoMasaru MimuraTetsuhiro YoshinoTatsuya NogamiMakoto AraiJuichi SatoKoichiro TanakaHajime NakaeHidetoshi IgariYoshihito OzawaYuki ShikoYohei KawasakiMasahiko NezuTakashi Ito

Published in: Trials (2021)

The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

randomized controlled trial
coronavirus disease
sars cov
study protocol
clinical trial
network analysis